Clinical trial
A Study to Investigate the Effect of Delayed Release Pancrelipase on…
NCT00414908 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00414908 |
|---|---|
| Title | A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy |
| Official title | A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Pancreatitis, Pancreatectomy, Pancreatic Exocrine Insufficiency |
| Intervention type | Drug |
| Interventions | Pancrelipase delayed release capsule, Placebo Comparator |
| Enrollment | 52 |
| Start date | Oct 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Dec 22, 2006 |
| Last update posted | Aug 10, 2011 |
| Countries | Bulgaria, Poland, Puerto Rico, Russia, Serbia, South Africa, Ukraine, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: